Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.325 USD | -4.73% | -8.22% | -33.70% |
May. 15 | PDS Biotechnology Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 10 | NetScientific says PDS Biotech's Versamune meets endpoints | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.70% | 128M | |
+9.72% | 115B | |
+11.68% | 106B | |
-2.59% | 21.96B | |
-13.30% | 21.87B | |
-5.29% | 19.21B | |
-4.27% | 18.08B | |
-38.57% | 17.71B | |
+6.50% | 14.32B | |
+33.98% | 12.42B |
- Stock Market
- Equities
- PDSB Stock
- News PDS Biotechnology Corporation
- Oppenheimer Adjusts PDS Biotechnology Price Target to $23 From $24, Maintains Outperform Rating